Cargando…
Are we at the Goal Line with the Novel Oral Anticoagulants and Have We Reached the End of the Line for Dronedarone and Vernakalant – or is There More to Come?
The authors of this Mini-Hot-Topic collection of review manuscripts have provided an outstanding review of the development and current status of several of our most recently developed agents in the fight against atrial fibrillation (AF). They have also given the readers a glimpse into the difficulty...
Autor principal: | Reiffel, James A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4101195/ https://www.ncbi.nlm.nih.gov/pubmed/25004988 http://dx.doi.org/10.2174/1573403X1004140707123143 |
Ejemplares similares
-
Decisions at the end of life: have we come of age?
por: Emanuel, Linda, et al.
Publicado: (2010) -
Fast-track hip and knee arthroplasty – have we reached the goal?
por: Wainwright, Thomas W, et al.
Publicado: (2019) -
We should have seen this coming
por: Schwarzkopf, D. Samuel
Publicado: (2014) -
Liver Regeneration by Hematopoietic Stem Cells: Have We Reached the End of the Road?
por: Siapati, Elena Konstantina, et al.
Publicado: (2022) -
Global end-diastolic volume an emerging preload marker vis-a-vis other markers - Have we reached our goal?
por: Kapoor, P. M, et al.
Publicado: (2016)